# Metallus Inc.: financial statements, quarterly

MTUS · NYSE · CIK 1598428 · [Materials](/sectors/materials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/mtus.md) · [Financials](/companies/mtus/financials.md) · [Filings](/companies/mtus/filings.md) · [Insiders](/companies/mtus/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/mtus/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [354](/filings/0000950170-24-123398.md) | [328 d](/filings/0001193125-26-061042.md) | [322](/filings/0000950170-25-066985.md) | [295](/filings/0000950170-25-105098.md) | [227](/filings/0001193125-25-269669.md) | [241 d](/filings/0001193125-26-061042.md) | [281](/filings/0001193125-26-205648.md) | [305](/filings/0001193125-26-332244.md) | [306](/filings/0001193125-25-269669.md) | [267 d](/filings/0001193125-26-061042.md) | [308](/filings/0001193125-26-205648.md) | [341](/filings/0001193125-26-332244.md) |
| Cost of revenue | $m | [303](/filings/0000950170-24-123398.md) | [287 d](/filings/0001193125-26-061042.md) | [271](/filings/0000950170-25-066985.md) | [271](/filings/0000950170-25-105098.md) | [215](/filings/0001193125-25-269669.md) | [230 d](/filings/0001193125-26-061042.md) | [259](/filings/0001193125-26-205648.md) | [272](/filings/0001193125-26-332244.md) | [271](/filings/0001193125-25-269669.md) | [261 d](/filings/0001193125-26-061042.md) | [283](/filings/0001193125-26-205648.md) | [307](/filings/0001193125-26-332244.md) |
| Gross profit | $m | [51.0](/filings/0000950170-24-123398.md) | [41.4 d](/filings/0001193125-26-061042.md) | [50.6](/filings/0000950170-25-066985.md) | [24.1](/filings/0000950170-25-105098.md) | [12.1](/filings/0001193125-25-269669.md) | [10.9 d](/filings/0001193125-26-061042.md) | [21.9](/filings/0001193125-26-205648.md) | [32.2](/filings/0001193125-26-332244.md) | [35.0](/filings/0001193125-25-269669.md) | [6.0 d](/filings/0001193125-26-061042.md) | [25.1](/filings/0001193125-26-205648.md) | [34.1](/filings/0001193125-26-332244.md) |
| Selling, general and administrative | $m | [20.5](/filings/0000950170-24-123398.md) | [22.7 d](/filings/0001193125-26-061042.md) | [24.1](/filings/0000950170-25-066985.md) | [20.7](/filings/0000950170-25-105098.md) | [22.5](/filings/0001193125-25-269669.md) | [20.4 d](/filings/0001193125-26-061042.md) | [24.3](/filings/0001193125-26-205648.md) | [22.9](/filings/0001193125-26-332244.md) | [24.5](/filings/0001193125-25-269669.md) | [22.3 d](/filings/0001193125-26-061042.md) | [22.2](/filings/0001193125-26-205648.md) | [23.7](/filings/0001193125-26-332244.md) |
| Operating income | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Interest expense | $m | [0.6](/filings/0000950170-23-058233.md) | [0.8 d](/filings/0000950170-24-022078.md) | [0.6](/filings/0000950170-25-066985.md) | [0.7](/filings/0000950170-24-094053.md) | not reported | not reported | [0.5](/filings/0000950170-25-066985.md) | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [9.8](/filings/0000950170-24-123398.md) | [2.4 d](/filings/0001193125-26-061042.md) | [6.0](/filings/0000950170-25-066985.md) | [1.5](/filings/0000950170-25-105098.md) | [(1.2)](/filings/0001193125-25-269669.md) | [(3.0) d](/filings/0001193125-26-061042.md) | [1.6](/filings/0001193125-26-205648.md) | [4.9](/filings/0001193125-26-332244.md) | [2.8](/filings/0001193125-25-269669.md) | [(6.2) d](/filings/0001193125-26-061042.md) | [2.6](/filings/0001193125-26-205648.md) | [3.0](/filings/0001193125-26-332244.md) |
| Net income | $m | [24.8](/filings/0000950170-24-123398.md) | [1.3 d](/filings/0001193125-26-061042.md) | [24.0](/filings/0001193125-25-269669.md) | [4.6](/filings/0001193125-25-269669.md) | [(5.9)](/filings/0001193125-25-269669.md) | [(21.4) d](/filings/0001193125-26-061042.md) | [1.3](/filings/0001193125-26-332244.md) | [3.7](/filings/0001193125-26-332244.md) | [8.1](/filings/0001193125-25-269669.md) | [(14.3) d](/filings/0001193125-26-061042.md) | [5.4](/filings/0001193125-26-332244.md) | [8.9](/filings/0001193125-26-332244.md) |
| Diluted EPS | $ per share | [0.51](/filings/0000950170-24-123398.md) | not reported | [0.52](/filings/0000950170-25-066985.md) | [0.10](/filings/0000950170-25-105098.md) | [(0.13)](/filings/0001193125-25-269669.md) | not reported | [0.03](/filings/0001193125-26-205648.md) | [0.09](/filings/0001193125-26-332244.md) | [0.19](/filings/0001193125-25-269669.md) | not reported | [0.13](/filings/0001193125-26-205648.md) | [0.21](/filings/0001193125-26-332244.md) |
| Basic EPS | $ per share | [0.56](/filings/0000950170-24-123398.md) | not reported | [0.55](/filings/0000950170-25-066985.md) | [0.10](/filings/0000950170-25-105098.md) | [(0.13)](/filings/0001193125-25-269669.md) | not reported | [0.03](/filings/0001193125-26-205648.md) | [0.09](/filings/0001193125-26-332244.md) | [0.19](/filings/0001193125-25-269669.md) | not reported | [0.13](/filings/0001193125-26-205648.md) | [0.21](/filings/0001193125-26-332244.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: not reported
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [225](/filings/0000950170-24-123398.md) | [281](/filings/0001193125-26-061042.md) | [278](/filings/0000950170-25-066985.md) | [273](/filings/0000950170-25-105098.md) | [255](/filings/0001193125-25-269669.md) | [241](/filings/0001193125-26-061042.md) | [180](/filings/0001193125-26-205648.md) | [191](/filings/0001193125-26-332244.md) | [192](/filings/0001193125-25-269669.md) | [157](/filings/0001193125-26-332244.md) | [104](/filings/0001193125-26-205648.md) | [109](/filings/0001193125-26-332244.md) |
| Current assets | $m | [631](/filings/0000950170-23-058233.md) | [657](/filings/0000950170-25-029085.md) | [648](/filings/0000950170-24-057033.md) | [607](/filings/0000950170-24-094053.md) | [602](/filings/0000950170-24-123398.md) | [587](/filings/0001193125-26-061042.md) | [568](/filings/0000950170-25-066985.md) | [561](/filings/0000950170-25-105098.md) | [580](/filings/0001193125-25-269669.md) | [553](/filings/0001193125-26-332244.md) | [552](/filings/0001193125-26-205648.md) | [551](/filings/0001193125-26-332244.md) |
| Total assets | $m | [1,154](/filings/0000950170-23-058233.md) | [1,175](/filings/0000950170-25-029085.md) | [1,166](/filings/0000950170-24-057033.md) | [1,120](/filings/0000950170-24-094053.md) | [1,133](/filings/0000950170-24-123398.md) | [1,117](/filings/0001193125-26-061042.md) | [1,102](/filings/0000950170-25-066985.md) | [1,112](/filings/0000950170-25-105098.md) | [1,150](/filings/0001193125-25-269669.md) | [1,140](/filings/0001193125-26-332244.md) | [1,138](/filings/0001193125-26-205648.md) | [1,143](/filings/0001193125-26-332244.md) |
| Current liabilities | $m | [207](/filings/0000950170-23-058233.md) | [248](/filings/0000950170-25-029085.md) | [239](/filings/0000950170-24-057033.md) | [195](/filings/0000950170-24-094053.md) | [228](/filings/0000950170-24-123398.md) | [282](/filings/0001193125-26-061042.md) | [280](/filings/0000950170-25-066985.md) | [276](/filings/0000950170-25-105098.md) | [305](/filings/0001193125-25-269669.md) | [315](/filings/0001193125-26-332244.md) | [319](/filings/0001193125-26-205648.md) | [315](/filings/0001193125-26-332244.md) |
| Total liabilities | $m | [424](/filings/0000950170-23-058233.md) | [444](/filings/0000950170-25-029085.md) | [427](/filings/0000950170-24-057033.md) | [384](/filings/0000950170-24-094053.md) | [421](/filings/0000950170-24-123398.md) | [426](/filings/0001193125-26-061042.md) | [415](/filings/0000950170-25-066985.md) | [422](/filings/0000950170-25-105098.md) | [453](/filings/0001193125-25-269669.md) | [454](/filings/0001193125-26-332244.md) | [455](/filings/0001193125-26-205648.md) | [451](/filings/0001193125-26-332244.md) |
| Long-term debt | $m | [0.0](/filings/0000950170-23-058233.md) | [0.0](/filings/0000950170-25-029085.md) | [0.0](/filings/0000950170-24-057033.md) | [0.0](/filings/0000950170-24-094053.md) | [0.0](/filings/0000950170-24-123398.md) | [0.0](/filings/0001193125-25-269669.md) | [0.0](/filings/0000950170-25-066985.md) | [0.0](/filings/0000950170-25-105098.md) | [0.0](/filings/0001193125-25-269669.md) | not reported | not reported | not reported |
| Current portion of debt | $m | [13.1](/filings/0000950170-23-058233.md) | [13.2](/filings/0000950170-25-029085.md) | [13.2](/filings/0000950170-24-057033.md) | [13.2](/filings/0000950170-24-094053.md) | [13.2](/filings/0000950170-24-123398.md) | [5.4](/filings/0001193125-25-269669.md) | [5.4](/filings/0000950170-25-066985.md) | [0.0](/filings/0000950170-25-105098.md) | [0.0](/filings/0001193125-25-269669.md) | not reported | not reported | not reported |
| Shareholders' equity | $m | [730](/filings/0000950170-24-123398.md) | [732](/filings/0001193125-26-061042.md) | [739](/filings/0001193125-25-269669.md) | [736](/filings/0001193125-25-269669.md) | [713](/filings/0001193125-25-269669.md) | [691](/filings/0001193125-26-332244.md) | [686](/filings/0001193125-26-332244.md) | [690](/filings/0001193125-26-332244.md) | [698](/filings/0001193125-25-269669.md) | [686](/filings/0001193125-26-332244.md) | [683](/filings/0001193125-26-332244.md) | [692](/filings/0001193125-26-332244.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [28.1 d](/filings/0000950170-24-123398.md) | [74.1 d](/filings/0001193125-26-061042.md) | [33.4](/filings/0000950170-25-066985.md) | [8.3 d](/filings/0000950170-25-105098.md) | [(15.3) d](/filings/0001193125-25-269669.md) | [13.9 d](/filings/0001193125-26-061042.md) | [(38.9)](/filings/0001193125-26-205648.md) | [34.8 d](/filings/0001193125-26-332244.md) | [22.0 d](/filings/0001193125-25-269669.md) | [(1.9) d](/filings/0001193125-26-061042.md) | [(26.9)](/filings/0001193125-26-205648.md) | [12.8 d](/filings/0001193125-26-332244.md) |
| Dividends paid | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Share repurchases | $m | [7.7 d](/filings/0000950170-24-123398.md) | [4.1 d](/filings/0001193125-26-061042.md) | [4.4](/filings/0000950170-25-066985.md) | [9.6 d](/filings/0000950170-25-105098.md) | [20.1 d](/filings/0001193125-25-269669.md) | [3.5 d](/filings/0001193125-26-061042.md) | [5.6](/filings/0001193125-26-205648.md) | [3.3 d](/filings/0001193125-26-332244.md) | [3.0 d](/filings/0001193125-25-269669.md) | [1.2 d](/filings/0001193125-26-061042.md) | [4.3](/filings/0001193125-26-205648.md) | [3.6 d](/filings/0001193125-26-332244.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Dividends paid: not reported
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [46.0](/filings/0000950170-23-058233.md) | [48.7](/filings/0000950170-24-057033.md) | [47.3](/filings/0000950170-24-094053.md) | [47.9](/filings/0000950170-24-123398.md) | [46.8](/filings/0000950170-25-066985.md) | [46.6](/filings/0000950170-25-105098.md) | [43.1](/filings/0001193125-25-269669.md) | [43.0](/filings/0001193125-26-205648.md) | [43.3](/filings/0001193125-26-332244.md) | [43.0](/filings/0001193125-25-269669.md) | [43.2](/filings/0001193125-26-205648.md) | [43.1](/filings/0001193125-26-332244.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 41,449,284 at 2026-07-31, from the cover of the [10-Q filed 2026-08-04](/filings/0001193125-26-332244.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:43 ET. No prices; not investment advice.